Format
Sort by
Items per page

Send to

Choose Destination

Best matches for TICAGRELOR/TU:

Ticagrelor: a review of its use in adults with acute coronary syndromes. Dhillon S et al. Am J Cardiovasc Drugs. (2015)

Ticagrelor: Pharmacokinetic, Pharmacodynamic and Pharmacogenetic Profile: An Update. Teng R et al. Clin Pharmacokinet. (2015)

Ticagrelor: pharmacokinetics, pharmacodynamics, clinical efficacy, and safety. Dobesh PP et al. Pharmacotherapy. (2014)

Search results

Items: 1 to 20 of 1338

1.
2.

Effect of Ticagrelor Plus Aspirin, Ticagrelor Alone, or Aspirin Alone on Saphenous Vein Graft Patency 1 Year After Coronary Artery Bypass Grafting: A Randomized Clinical Trial.

Zhao Q, Zhu Y, Xu Z, Cheng Z, Mei J, Chen X, Wang X.

JAMA. 2018 Apr 24;319(16):1677-1686. doi: 10.1001/jama.2018.3197.

PMID:
29710164
3.

Comparative study of ticagrelor and clopidogrel in therapeutic effect of acute myocardial infarction patients undergoing percutaneous coronary intervention.

Yao G, Su G, Li K, Li B, Dong H.

Saudi J Biol Sci. 2017 Dec;24(8):1818-1820. doi: 10.1016/j.sjbs.2017.11.020. Epub 2017 Nov 10.

4.

Epidemiology and Management of Patients With Acute Coronary Syndromes in Contemporary Real-World Practice: Evolving Trends From the EYESHOT Study to the START-ANTIPLATELET Registry.

Calabrò P, Gragnano F, di Maio M, Patti G, Antonucci E, Cirillo P, Gresele P, Palareti G, Pengo V, Pignatelli P, Pennacchi M, Granatelli A, De Servi S, De Luca L, Marcucci R; for EYESHOT Study and Start Antiplatelet Register.

Angiology. 2018 Jan 1:3319718760917. doi: 10.1177/0003319718760917. [Epub ahead of print]

PMID:
29544348
5.

European Society of Cardiology Congress 2017 (August 26-30, 2017 - Barcelona, Spain).

Klischies S.

Drugs Today (Barc). 2017 Dec;53(12):667-670. doi: 10.1358/dot.2017.53.12.2717629.

PMID:
29517085
6.

Peripheral artery disease and antiplatelet treatment.

Tsigkou V, Siasos G, Rovos K, Tripyla N, Tousoulis D.

Curr Opin Pharmacol. 2018 Feb 19;39:43-52. doi: 10.1016/j.coph.2018.01.011. [Epub ahead of print] Review.

PMID:
29471161
7.

The promise of effective P2Y12 platelet receptor pretreatment: Not crushed yet.

Chatterjee A, Hillegass WB.

Catheter Cardiovasc Interv. 2018 Feb 1;91(2):251-252. doi: 10.1002/ccd.27512.

PMID:
29405601
8.

Successful coronary stenting in a patient with factor V deficiency in the absence of fresh frozen plasma transfusion: Case report.

Choi S, Song M.

Medicine (Baltimore). 2017 Dec;96(50):e9274. doi: 10.1097/MD.0000000000009274.

9.

P2Y12 receptor inhibitors: an evolution in drug design to prevent arterial thrombosis.

Kupka D, Sibbing D.

Expert Opin Drug Metab Toxicol. 2018 Mar;14(3):303-315. doi: 10.1080/17425255.2018.1428557. Epub 2018 Jan 23. Review.

PMID:
29338536
10.
11.

Ticagrelor in modern cardiology - an up-to-date review of most important aspects of ticagrelor pharmacotherapy.

Danielak D, Karaźniewicz-Łada M, Główka F.

Expert Opin Pharmacother. 2018 Feb;19(2):103-112. doi: 10.1080/14656566.2017.1421634. Epub 2017 Dec 27. Review.

PMID:
29280403
12.

Effects of four antiplatelet/statin combined strategies on immune and inflammatory responses in patients with acute myocardial infarction undergoing pharmacoinvasive strategy: Design and rationale of the B and T Types of Lymphocytes Evaluation in Acute Myocardial Infarction (BATTLE-AMI) study: study protocol for a randomized controlled trial.

Fonseca FAH, Izar MC, Maugeri IML, Berwanger O, Damiani LP, Pinto IM, Szarf G, França CN, Bianco HT, Moreira FT, Caixeta A, Alves CMR, Soriano Lopes A, Klassen A, Tavares MFM, Fonseca HA, Carvalho ACC; BATTLE-AMI Investigators.

Trials. 2017 Dec 19;18(1):601. doi: 10.1186/s13063-017-2361-1.

13.

Management and predictors of outcome in unselected patients with cardiogenic shock complicating acute ST-segment elevation myocardial infarction: results from the Bremen STEMI Registry.

Backhaus T, Fach A, Schmucker J, Fiehn E, Garstka D, Stehmeier J, Hambrecht R, Wienbergen H.

Clin Res Cardiol. 2018 May;107(5):371-379. doi: 10.1007/s00392-017-1192-0. Epub 2017 Dec 11.

PMID:
29230546
14.

Efficacy and safety of potent platelet P2Y12 receptor inhibitors in elderly versus nonelderly patients with acute coronary syndrome: A systematic review and meta-analysis.

Tarantini G, Ueshima D, D'Amico G, Masiero G, Musumeci G, Stone GW, Brener SJ.

Am Heart J. 2018 Jan;195:78-85. doi: 10.1016/j.ahj.2017.09.012. Epub 2017 Sep 21. Review.

PMID:
29224649
15.

The use of alternatives to clopidogrel in flow-diversion treatment with the Pipeline embolization device.

Atallah E, Saad H, Bekelis K, Chalouhi N, Tjoumakaris S, Hasan D, Eller J, Stidd D, Rosenwasser RH, Jabbour P.

J Neurosurg. 2017 Dec 8:1-6. doi: 10.3171/2017.5.JNS162663. [Epub ahead of print]

PMID:
29219758
16.

Bleeding in advanced CKD patients on antithrombotic medication - A critical appraisal.

Burlacu A, Genovesi S, Goldsmith D, Rossignol P, Ortiz A, Kalra PA, Małyszko J, Banach M, Kanbay M, Covic A.

Pharmacol Res. 2018 Mar;129:535-543. doi: 10.1016/j.phrs.2017.12.004. Epub 2017 Dec 5.

PMID:
29208494
17.

Antiplatelet Effect of Different Loading Doses of Ticagrelor in Patients With Non-ST-Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: The APELOT Trial.

Liu HL, Wei YJ, Ding P, Zhang J, Li TC, Wang B, Wang MS, Li YT, Zhang JJ, Ren YH, Tang Q, Luo JP, Yang SL, Ma HY, Liu Y, Han W, Li Y, Jin ZG, Jin LM.

Can J Cardiol. 2017 Dec;33(12):1675-1682. doi: 10.1016/j.cjca.2017.09.002. Epub 2017 Sep 12.

PMID:
29173606
18.

Ticagrelor Leads to Statin-Induced Rhabdomyolysis: A Case Report.

Mrotzek SM, Rassaf T, Totzeck M.

Am J Case Rep. 2017 Nov 23;18:1238-1241.

19.

Antithrombotic treatment in peripheral artery disease.

Olinic DM, Tataru DA, Homorodean C, Spinu M, Olinic M.

Vasa. 2018 Feb;47(2):99-108. doi: 10.1024/0301-1526/a000676. Epub 2017 Nov 21. Review.

PMID:
29160765
20.

Real-world clopidogrel utilization in acute coronary syndromes: patients selection and outcomes in a single-center experience.

Castini D, Persampieri S, Cazzaniga S, Ferrante G, Centola M, Lucreziotti S, Salerno-Uriarte D, Sponzilli C, Carugo S.

Ther Adv Cardiovasc Dis. 2017 Dec;11(12):323-331. doi: 10.1177/1753944717738911.

Supplemental Content

Loading ...
Support Center